WHO ICTRP trial
Global evidence for asthma exacerbation in long term management
JPRN-UMIN000003250 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000003250 |
|---|---|
| Public title | Global evidence for asthma exacerbation in long term management |
| Scientific title | Global evidence for asthma exacerbation in long term management - GAIA Study |
| Primary sponsor | GAIA Study Research Group |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Bronchial asthma |
| Interventions | Subjects will take one sachet of carbocisteine granules (containing 500 mg of L- carbocisteine per sachet) three times daily after meals for 48 weeks. Subjects will take one sachet of placebo granules (not containing L- carbocisteine) three… |
| Registration date | Dec 31, 2011 |
| Target size | 250 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: